Tsadik T. Abraham

Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.

R. Herning, J. Cadet, M. Huestis, 2009, Drug and alcohol dependence.

xtended urinary 9-tetrahydrocannabinol excretion in chronic cannabis sers precludes use as a biomarker of new drug exposure oss

R. Herning, M. Huestis, H. Lowe, 2009 .

Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.

Marilyn A Huestis, M. Huestis, D. Gorelick, 2009, Journal of analytical toxicology.

Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.

M. Huestis, S. Pirnay, Tsadik T. Abraham, 2006, Clinical chemistry.

Simultaneous GC–EI-MS Determination of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, and 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Human Urine Following Tandem Enzyme-Alkaline Hydrolysis

M. Huestis, S. Pirnay, Ross H. Lowe, 2007 .

Excretion of Δ9-Tetrahydrocannabinol in Sweat

Richard A. Gustafson, M. Huestis, Takeshi Saito, 2008 .

Excretion of Delta9-tetrahydrocannabinol in sweat.

Richard A. Gustafson, M. Huestis, Takeshi Saito, 2008, Forensic Science International.

Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA.

M. Huestis, S. Pirnay, Ross H. Lowe, 2006, Journal of analytical toxicology.